Chou Kuo-Chen
Gordon Life Science Institute, Boston, MA 02478, United States of America; Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu 610054, China.
Genomics. 2019 Aug 30. doi: 10.1016/j.ygeno.2019.08.008.
This article has been withdrawn at the request of the Editor-in-Chief. After a thorough investigation, the Editor has concluded that the acceptance of this article was partly based upon the positive advice of two illegitimate reviewer reports. The reports were submitted from email accounts which were provided to the journal as suggested reviewers during the submission of the article. Although purportedly real reviewer accounts, the Editor has concluded that these were not of appropriate, independent reviewers. Also, the article duplicates significant parts of a paper that had already appeared in Current Medicinal Chemistry 26 (2019) 4918-4943 https://doi.org/10.2174/0929867326666190507082559. This represents a clear violation of the fundamentals of peer review, our publishing policies, and publishing ethics standards. Apologies are offered to the readers of the journal that this was not detected during the submission process. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
应主编要求,本文已被撤回。经过全面调查,主编得出结论,该文章的录用部分基于两份非法审稿报告的正面意见。这些报告是从文章投稿时作为建议审稿人提供给期刊的电子邮箱账号提交的。尽管据称是真实的审稿人账号,但主编认定这些并非合适的独立审稿人账号。此外,本文重复了一篇已发表于《当代药物化学》26 (2019) 4918 - 4943 https://doi.org/10.2174/0929867326666190507082559 的论文的重要部分。这明显违反了同行评审的基本原则、我们的出版政策以及出版道德标准。对于在投稿过程中未检测到这一情况,我们向本刊读者表示歉意。完整的爱思唯尔文章撤回政策可在https://www.elsevier.com/about/our-business/policies/article-withdrawal查询。